Huadong Medicine Co Ltd (000963) — Capital Reinvestment Ratio
Huadong Medicine Co Ltd (000963) has a Capital Reinvestment Ratio of 1.90x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥155.98 Million) in capital expenditures (CN¥297.09 Million). Check tangible equity quality of Huadong Medicine Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Huadong Medicine Co Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Huadong Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see 000963 cash flow conversion.
Annual Capital Reinvestment Ratio for Huadong Medicine Co Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Huadong Medicine Co Ltd from 1998 to 2024. See cash generation quality of Huadong Medicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥3.75 Billion | CN¥1.73 Billion | ▲ +12.7% |
| 2023 | 0.41x | CN¥3.93 Billion | CN¥1.61 Billion | ▼ -18.4% |
| 2022 | 0.50x | CN¥2.38 Billion | CN¥1.19 Billion | ▲ +93.9% |
| 2021 | 0.26x | CN¥3.17 Billion | CN¥819.10 Million | ▼ -40.2% |
| 2020 | 0.43x | CN¥3.41 Billion | CN¥1.47 Billion | ▼ -36.1% |
| 2019 | 0.68x | CN¥2.00 Billion | CN¥1.35 Billion | ▲ +57.3% |
| 2018 | 0.43x | CN¥2.04 Billion | CN¥876.46 Million | ▲ +49.1% |
| 2017 | 0.29x | CN¥1.66 Billion | CN¥478.69 Million | ▼ -16.9% |
| 2016 | 0.35x | CN¥1.35 Billion | CN¥467.00 Million | ▼ -40.4% |
| 2015 | 0.58x | CN¥658.54 Million | CN¥383.01 Million | ▲ +32.6% |
| 2014 | 0.44x | CN¥740.85 Million | CN¥324.89 Million | ▼ -37.7% |
| 2013 | 0.70x | CN¥476.98 Million | CN¥335.84 Million | ▲ +76.1% |
| 2012 | 0.40x | CN¥642.73 Million | CN¥256.97 Million | ▼ -97.1% |
| 2011 | 13.91x | CN¥16.12 Million | CN¥224.21 Million | ▲ +6009.9% |
| 2009 | 0.23x | CN¥567.94 Million | CN¥129.26 Million | ▼ -11.1% |
| 2008 | 0.26x | CN¥344.69 Million | CN¥88.24 Million | ▲ +110.8% |
| 2007 | 0.12x | CN¥265.79 Million | CN¥32.27 Million | ▼ -91.7% |
| 2006 | 1.46x | CN¥57.38 Million | CN¥83.53 Million | ▲ +492.0% |
| 2005 | 0.25x | CN¥203.33 Million | CN¥50.00 Million | ▼ -95.4% |
| 2004 | 5.33x | CN¥12.51 Million | CN¥66.60 Million | ▲ +558.2% |
| 2003 | 0.81x | CN¥90.54 Million | CN¥73.24 Million | ▼ -65.7% |
| 2002 | 2.36x | CN¥23.94 Million | CN¥56.47 Million | ▲ +386.1% |
| 2001 | 0.49x | CN¥109.67 Million | CN¥53.21 Million | ▼ -85.6% |
| 2000 | 3.37x | CN¥19.59 Million | CN¥66.01 Million | ▲ +1565.3% |
| 1999 | 0.20x | CN¥56.32 Million | CN¥11.40 Million | ▼ -62.1% |
| 1998 | 0.53x | CN¥23.80 Million | CN¥12.70 Million | — |